The fragility index in multicenter randomized controlled critical care trials

Critical Care Medicine

Volumn 44, Issue 7, 2016, Pages 1278-1284

  Ridgeon, Elliott E ^a,b   Young, Paul J ^a,b   Bellomo, Rinaldo ^c,d   Mucchetti, Marta ^e   Lembo, Rosalba ^e   Landoni, Giovanni ^e,f  

^a WELLINGTON HOSPITAL   (New Zealand)

^b MEDICAL RESEARCH INSTITUTE OF NEW ZEALAND   (New Zealand)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d MONASH UNIVERSITY   (Australia)

^e SAN RAFFAELE HOSPITAL   (Italy)

^f VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

Author keywords

critical care; intensive care; lost to follow up; mortality; randomized controlled trials; research methodology

Indexed keywords

ARTICLE; CALCULATION; FOLLOW UP; FRAGILITY INDEX; HUMAN; INTENSIVE CARE; MORTALITY; MULTICENTER STUDY (TOPIC); PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SAMPLE SIZE; STATISTICAL CONCEPTS; STATISTICAL DISTRIBUTION; STATISTICAL ANALYSIS; STATISTICS AND NUMERICAL DATA;

CRITICAL CARE; DATA INTERPRETATION, STATISTICAL; HUMANS; MORTALITY; MULTICENTER STUDIES AS TOPIC; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84960455175     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0000000000001670     Document Type: Article

References (22)

1. Halpern NA, Pastores SM. Critical care medicine in the United States 2000-2005: An analysis of bed numbers, occupancy rates, payer mix, and costs. Crit Care Med 2010; 38:65-71
2. Vincent JL, Marshall JC, Namendys-Silva SA, et al; ICON Investigators: Assessment of the worldwide burden of critical illness: The intensive care over nations (ICON) audit. Lancet Respir Med 2014; 2:380-386
3. Landoni G, Comis M, Conte M, et al. Mortality in Multicenter Critical Care Trials: An analysis of interventions with a significant effect. Crit Care Med 2015; 43:1559-1568
4. Sterne JA, Davey Smith G. Sifting the evidence-what?s wrong with significance tests?. BMJ 2001; 322:226-231
5. Rozeboom WW. The fallacy of the null-hypothesis significance test. Psychol Bull 1960; 57:416-428
6. Rothman KJ. Significance questing. Ann Intern Med 1986; 105:445-447
7. Goodman SN. Toward evidence-based medical statistics. 1: The P value fallacy. Ann Intern Med 1999; 130:995-1004
8. McIlroy D. Seduced by a P-value. Anaesth Intensive Care 2014; 42:551-554
9. Walsh M, Srinathan SK, McAuley DF, et al. The statistical significance of randomized controlled trial results is frequently fragile: A case for a Fragility Index. J Clin Epidemiol 2014; 67:622-628
10. Bender R. Calculating confidence intervals for the number needed to treat. Control Clin Trials 2001; 22:102-110
11. Evaniew N, Files C, Smith C, et al. The fragility of statistically significant findings from randomized trials in spine surgery: A systematic survey. Spine J 2015; 15:2188-2197
12. Aberegg SK, Richards DR, O'Brien JM. Delta inflation: A bias in the design of randomized controlled trials in critical care medicine. Crit Care 2010; 14:R77
13. Harhay MO, Wagner J, Ratcliffe SJ, et al. Outcomes and statistical power in adult critical care randomized trials. Am J Respir Crit Care Med 2014; 189:1469-1478
14. Gibbs NM, Weightman WM. An audit of the statistical validity of conclusions of clinical superiority in anaesthesia journals. Anaesth Intensive Care 2014; 42:599-607
15. Psaty BM, Prentice RL. Minimizing bias in randomized trials: The importance of blinding. JAMA 2010; 304:793-794
16. Freemantle N. Interpreting the results of secondary end points and subgroup analyses in clinical trials: Should we lock the crazy aunt in the attic?. BMJ 2001; 322:989-991
17. Young PJ, Weatherall M, Saxena MK, et al; Australian and New Zealand Intensive Care Society Clinical Trials Group: Statistical analysis plan for the HEAT trial: A multicentre randomised placebo-controlled trial of intravenous paracetamol in intensive care unit patients with fever and infection. Crit Care Resusc 2013; 15:279-286
18. Venkatesh B, Myburgh J, Finfer S, et al; ANZICS CTG Investigators: The ADRENAL study protocol: Adjunctive corticosteroid treatment in critically ill patients with septic shock. Crit Care Resusc 2013; 15:83-88
19. Reddy SK, Bailey MJ, Beasley RW, et al. A protocol for the 0.9% saline versus Plasma-Lyte 148 for intensive care fluid therapy (SPLIT) study. Crit Care Resusc 2014; 16:274-279
20. Power GS, Harrison DA, Mouncey PR, et al. The Protocolised Management in Sepsis (ProMISe) trial statistical analysis plan. Crit Care Resusc 2013; 15:311-317
21. Pike F, Yealy DM, Kellum JA, et al; ProCESS Investigators: Protocolized Care for Early Septic Shock (ProCESS) statistical analysis plan. Crit Care Resusc 2013; 15:301-310
22. Litton E, Baker S, Erber W, et al; Australian and New Zealand Intensive Care Society Clinical Trials Group: The IRONMAN trial: A protocol for a multicentre randomised placebo-controlled trial of intravenous iron in intensive care unit patients with anaemia. Crit Care Resusc 2014; 16:285-290